Table 2.
Univariate and multivariate analyses of CSS in ESCC patients.
| CSS % | P value | Univariate analysis HR (95% CI) |
P value | Multivariate analysis HR (95% CI) |
P value | |
|---|---|---|---|---|---|---|
| Age (years) | 0.579 | 0.583 | — | — | ||
| ≤60 | 38.0 | 1.000 | ||||
| >60 | 36.1 | 1.088 (0.806–1.468) | ||||
| Gender | 0.182 | 0.189 | — | — | ||
| Female | 51.4 | 1.000 | ||||
| Male | 35.0 | 1.387 (0.851–2.260) | ||||
| Tumor length (cm) | <0.001 | 0.001 | 0.385 | |||
| ≤3.0 | 53.8 | 1.000 | 1.000 | |||
| >3.0 | 30.7 | 1.918 (1.328–2.769) | 1.198 (0.797–1.799) | |||
| Tumor location | 0.331 | 0.337 | — | — | ||
| Upper/middle | 41.3 | 1.000 | ||||
| Lower | 32.8 | 1.157 (0.859–1.558) | ||||
| Vessel invasion | 0.003 | 0.003 | 0.547 | |||
| Negative | 40.5 | 1.000 | 1.000 | |||
| Positive | 20.0 | 1.738 (1.203–2.511) | 1.125 (0.767–1.652) | |||
| Differentiation | 0.029 | 0.033 | 0.061 | |||
| Well/moderate | 39.2 | 1.000 | 1.000 | |||
| Poor | 29.1 | 1.476 (1.033–2.109) | 1.418 (0.984–2.043) | |||
| T stage | <0.001 | <0.001 | 0.011 | |||
| T1-2 | 57.7 | 1.000 | 1.000 | |||
| T3-4 | 26.1 | 2.371 (1.668–3.369) | 1.683 (1.129–2.508) | |||
| N stage | <0.001 | <0.001 | <0.001 | |||
| N0 | 54.7 | 1.000 | 1.000 | |||
| N1–3 | 16.5 | 2.846 (2.089–3.877) | 2.279 (1.640–3.165) | |||
| Adjuvant therapy | 0.121 | 0.126 | — | — | ||
| No | 40.3 | 1.000 | ||||
| Yes | 30.2 | 1.277 (0.934–1.746) | ||||
| RDW (%) | <0.001 | <0.001 | 0.036 | |||
| <14.5 | 43.9 | 1.000 | 1.000 | |||
| ≥14.5 | 23.3 | 1.719 (1.268–2.331) | 1.396 (1.022–1.908) |